136 related articles for article (PubMed ID: 6576383)
21. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
Teicher BA; Holden SA; Crawford JM
Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649
[TBL] [Abstract][Full Text] [Related]
22. Fundamental and clinical studies on intracadaveric organ perfusion with Fluosol-DA.
Honda K
Prog Clin Biol Res; 1983; 122():327-30. PubMed ID: 6348786
[No Abstract] [Full Text] [Related]
23. Increased radiosensitivity of tumors by perfluorochemicals and carbogen.
Song CW; Zhang WL; Pence DM; Lee I; Levitt SH
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1833-6. PubMed ID: 3930442
[TBL] [Abstract][Full Text] [Related]
24. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
25. Use of Fluosol-DA during open-heart surgery.
Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
[TBL] [Abstract][Full Text] [Related]
27. Fluorocarbons and the microcirculation.
Faithfull NS; Fennema M; Van Alphen WA; Smith AR; Erdmann W; Essed CE; Kok A; Lapin R
Acta Anaesthesiol Belg; 1984; 35 Suppl():69-78. PubMed ID: 6516761
[TBL] [Abstract][Full Text] [Related]
28. Maternal and fetal effects of exchange transfusion with a red blood cell substitute.
Cefalo RC; Seeds JW; Proctor HJ; Baker VV
Am J Obstet Gynecol; 1984 Apr; 148(7):859-67. PubMed ID: 6711627
[TBL] [Abstract][Full Text] [Related]
29. The effect of hemodilution with fluorocarbon or dextran on regional myocardial flow and function during acute coronary stenosis in the pig.
Biro GP; White FC; Guth BD; Breisch EA; Bloor CM
Am J Cardiovasc Pathol; 1987 Jan; 1(1):99-114. PubMed ID: 2458118
[TBL] [Abstract][Full Text] [Related]
30. Effect of oxygen-carrying resuscitation fluids on the pharmacokinetics of antipyrine, diazepam, penicillin, and sulfamethazine in rats.
Kemner JM; Snodgrass WR; Worley SE; Hodges GR; Melethil S; Hignite CE; Tschanz C
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):381-400. PubMed ID: 6515128
[TBL] [Abstract][Full Text] [Related]
31. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
[No Abstract] [Full Text] [Related]
32. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
[TBL] [Abstract][Full Text] [Related]
33. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
[No Abstract] [Full Text] [Related]
34. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Suyama T; Yokoyama K; Naito R
Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
[TBL] [Abstract][Full Text] [Related]
35. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
Swann KW; Ropper AH; Zervas NT
Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
[TBL] [Abstract][Full Text] [Related]
36. The effects of fetal exchange transfusion with a red blood cell substitute.
Ambrose A; Cefalo RC; Bowes WA
Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209
[TBL] [Abstract][Full Text] [Related]
37. Effect of perfluorochemicals on BCNU chemotherapy: preliminary study in a rat brain tumor model.
Kokunai T; Kuwamura K
Surg Neurol; 1982 Oct; 18(4):258-61. PubMed ID: 7179085
[TBL] [Abstract][Full Text] [Related]
38. Red cell substitutes: hemoglobin solution or fluorocarbon?
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
[TBL] [Abstract][Full Text] [Related]
39. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
Mitsuno T; Ohyanagi H; Naito R
Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
[TBL] [Abstract][Full Text] [Related]
40. [Artificial blood. Experimental studies on fluorocarbons as chemical blood substitutes].
Motta G; Grunert A; Herrmann M; Ratto GB; Spinelli E; Lunghi C; Tomellini M; Bisio E; Hirlinger WK; Mayer M
Minerva Med; 1983 Jan; 74(1-2):1-18. PubMed ID: 6337348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
